Orthofix International NV (OFIX) : Consonance Capital Management Lp reduced its stake in Orthofix International NV by 18.69% during the most recent quarter end. The investment management company now holds a total of 1,224,496 shares of Orthofix International NV which is valued at $53,302,311 after selling 281,400 shares in Orthofix International NV , the firm said in a disclosure report filed with the SEC on Aug 15, 2016.Orthofix International NV makes up approximately 6.37% of Consonance Capital Management Lp’s portfolio.
Other Hedge Funds, Including , Two Sigma Advisers Lp boosted its stake in OFIX in the latest quarter, The investment management firm added 2,200 additional shares and now holds a total of 130,574 shares of Orthofix International NV which is valued at $5,683,886. Orthofix International NV makes up approx 0.03% of Two Sigma Advisers Lp’s portfolio.Globeflex Capital L P boosted its stake in OFIX in the latest quarter, The investment management firm added 4,224 additional shares and now holds a total of 4,260 shares of Orthofix International NV which is valued at $185,438. Orthofix International NV makes up approx 0.05% of Globeflex Capital L P’s portfolio. Acrospire Investment Management sold out all of its stake in OFIX during the most recent quarter. The investment firm sold 1,404 shares of OFIX which is valued $59,628.American Century Companies Inc boosted its stake in OFIX in the latest quarter, The investment management firm added 11,605 additional shares and now holds a total of 30,275 shares of Orthofix International NV which is valued at $1,431,705. Cwm sold out all of its stake in OFIX during the most recent quarter. The investment firm sold 119 shares of OFIX which is valued $5,626.
Orthofix International NV opened for trading at $45.02 and hit $45.55 on the upside on Thursday, eventually ending the session at $45.52, with a gain of 0.91% or 0.41 points. The heightened volatility saw the trading volume jump to 1,44,003 shares. Company has a market cap of $825 M.
On the company’s financial health, Orthofix International NV reported $0.41 EPS for the quarter, beating the analyst consensus estimate by $ 0.08 according to the earnings call on Aug 1, 2016. Analyst had a consensus of $0.33. The company had revenue of $104.08 million for the quarter, compared to analysts expectations of $102.40 million. The company’s revenue was up 3.1% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.36 EPS.
Orthofix International N.V. (Orthofix) is a diversified global medical device company focused on providing reconstructive and regenerative orthopedic and spine solutions to physicians across the world. The company operates in four segments: BioStim Biologics Extremity Fixation and Spine Fixation. Its BioStim solutions products include Cervical-Stim Spinal-Stim and Physio-Stim. Its Biologic solutions products include AlloQuent Structural Allografts Trinity ELITE and Trinity Evolution among others. Its Extremity Fixation solutions include Fixator and Galaxy Fixation System among others. Its Spine Fixation solutions products include NewBridge Laminoplasty Fixation System and PILLAR PL & TL PEEK VBR System among others. It uses independent distributors as well as directly distributes its products in the United States Italy the United Kingdom Germany Switzerland Austria France Brazil Australia and Puerto Rico.